InvestorsObserver
×
News Home

Is Tenax Therapeutics Inc (TENX) Stock at the Top of the Biotechnology Industry?

Friday, April 09, 2021 09:56 AM | InvestorsObserver Analysts

Mentioned in this article

Is Tenax Therapeutics Inc (TENX) Stock at the Top of the Biotechnology Industry?

Tenax Therapeutics Inc (TENX) is near the top in its industry group according to InvestorsObserver. TENX gets an overall rating of 57. That means it scores higher than 57 percent of stocks. Tenax Therapeutics Inc gets a 86 rank in the Biotechnology industry. Biotechnology is number 83 out of 148 industries.

Overall Score - 57
TENX has an Overall Score of 57. Find out what this means to you and get the rest of the rankings on TENX!

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. Investors Observer makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts.

Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Tenax Therapeutics Inc Stock Today?

Tenax Therapeutics Inc (TENX) stock is trading at $2.10 as of 9:53 AM on Friday, Apr 9, a gain of $0.32, or 17.98% from the previous closing price of $1.78. Volume today is more active than usual. So far 14,638,471 shares have traded compared to average volume of 256,748 shares. The stock has traded between $2.03 and $2.47 so far today.

Click Here to get the full Stock Score Report on Tenax Therapeutics Inc (TENX) Stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App